Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Recent Developments in NMIBC Research
9
Mins
January 2026
Globally, there are more than 650,000 newly diagnosed cases of bladder cancer annually, with up to approximately 80% of these cases…
Read more
10
Mins
21 Sep 2020
Changing Paradigms in the Treatment of Advanced Urothelial Carcinoma: A 2020 Update
Urothelial cancer is the 9th most common cancer in the world and the 10th most common cancer in the UK…
7
Mins
17 Sep 2020
Editor's Pick: Tumour-Associated Hypoxia: Can We Give Chimeric Antigen Receptor T Cells More Breathing Space?
Chimeric antigen receptors (CAR) are fusion molecules that couple the binding of a native tumour-associated target to the delivery of a bespoke T…
9
Mins
17 Sep 2020
Metastasis: A Bane of Breast Cancer Therapy
Breast cancer is one of the most commonly diagnosed cancers among women.1 Despite advances in treatment for breast cancer…
12
Mins
17 Sep 2020
Putting into Perspective the Future of Cancer Vaccines: Targeted Immunotherapy
Cancer is a genetic and epigenetic disease of multicellularity, driving transformed cells to uncontrolled growth, invasion, and metastasis. In cancer, intracellular mechanisms controlling cellular proliferation are damaged first, which allows certain cells to progress to malignant transformation…
14
Mins
10 Sep 2020
Unmet Medical Need in Patients with Metastatic Colorectal Cancer with BRAF V600E Mutations: A Review
Colorectal cancer (CRC) is the most common gastrointestinal malignancy. Worldwide, it is the second most common cancer in females…
8
Mins
26 Aug 2020
Review of the Latest Developments in Treatment of Hormone Receptor-Positive Advanced Breast Cancer
MONARCH 2 was a global, randomised, double-blind, Phase III study of abemaciclib or placebo in combination with fulvestrant in premenopausal…
14
Mins
26 Aug 2020
Latest Developments in Advanced Breast Cancer Treatment: A Discussion with Two Key Opinion Leaders about the CDK4/6 Inhibitors Abemaciclib, Palbociclib, and Ribociclib
The introduction of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors in the treatment of advanced breast cancer (ABC; inoperable locally advanced…
10
Mins
24 Aug 2020
Adaptations and Advancement of Biologic Immunotherapy in the Management of Immunologically Cold Solid Malignancies
Contemporary breakthroughs within cancer immunotherapy are frequently cited amongst the most promising of therapeutic directions for medical oncology…
Loading posts...
« Previous
1
…
14
15
16
17
18
…
31
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View